GN Hearing's CEO regards new OTC regulation positively

The framework for the future over-the-counter sales channel in the US extends beyond what CEO Gitte Aabo had anticipated. Overall, she is pleasantly surprised.

Photo: GN Store Nord / PR

The framework of the upcoming US sales channel for over-the-counter (OTC) hearing aids was recently made public, and the big hearing aid manufacturers have been reading the over 100-page document from the US Food and Drug Administration carefully.

So far, CEO at GN Hearing Gitte Aabo's opinion is positive, she explains.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs